Experimental and investigational phosphodiesterase inhibitors in development for asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Experimental and investigational phosphodiesterase inhibitors in development for asthma

Published:2019-01-24 Issue:3 Volume:28 Page:261-266
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Ntontsi Polyxeni¹,Detta Aggeliki²,Bakakos Petros²,Loukides Stelios¹,Hillas Georgios³

Affiliation:

1. 2nd Respiratory Medicine Department, National and Kapodistrian University of Athens, Medical School, Attikon Hospital, Athens, Greece

2. 1st Respiratory Medicine Department, National and Kapodistrian University of Athens, Medical School, Sotiria Chest Hospital, Athens, Greece

3. 5th Pulmonary Department, “Sotiria” Chest Diseases Hospital, Athens, Greece

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1571582

Reference80 articles.

1. Asthma heterogeneity and severity

2. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

3. Novel signal transduction modulators for the treatment of airway diseases

4. Managing asthma in the real world

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Transforming Growth Factor-β (TGF-β) in Asthma and Chronic Obstructive Pulmonary Disease (COPD);Cells;2024-07-29

2. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19;Drug Metabolism and Personalized Therapy;2023-08-24

3. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19;Drug Metabolism and Personalized Therapy;2023-08-24

4. Pathogenesis of pulmonary hypertension caused by left heart disease;Frontiers in Cardiovascular Medicine;2023-03-03

5. Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules;Frontiers in Pharmacology;2022-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3